GSK Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK Pharma Quarterly Results    (GLXO)

Here are the latest quarterly results of GSK Pharma. For more details, see the GSK Pharma financial fact sheet and GSK Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

GSK Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
3
Mar-20
3
Jun-20
8-Qtr Chart
Click to enlarge
Net Sales Rs m8,1638,2547,5127,8808,8217,7877,7596,487 
Other income Rs m148164525305156163152578 
Turnover Rs m8,3118,4188,0378,1868,9777,9497,9107,064 
Expenses Rs m6,5126,8805,8766,2256,8796,5406,0185,343 
Gross profit Rs m1,5341,6551,6051,6555,954-6,1231,8541,144 
Depreciation Rs m115120137191227183226218 
Interest Rs m21199301511 
Profit before tax Rs m1,5651,6981,9921,7605,874-6,1731,7641,493 
Tax Rs m557568761626846268385383 
Profit after tax Rs m1,0081,1301,2301,1355,028-6,4411,3791,110 
Gross profit margin %18.820.021.421.067.5-78.623.917.6 
Effective tax rate %35.633.538.235.514.4-4.321.825.7 
Net profit margin %12.313.716.414.457.0-82.717.817.1 
Diluted EPS Rs 5.9 6.7 7.3 6.7 29.7 -38.0 8.1 6.5  
Diluted EPS (TTM) Rs 22.7 24.1 25.1 26.6 50.3 5.6 6.5 6.3  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: GSK Pharma 1QFY21 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   AJANTA PHARMA  VENUS REMEDIES  PIRAMAL ENTERPRISES  ASTRAZENECA PHARMA  TTK HEALTHCARE  

Compare GSK PHARMA With:   AJANTA PHARMA  VENUS REMEDIES  PIRAMAL ENTERPRISES  ASTRAZENECA PHARMA  TTK HEALTHCARE  

Compare GSK PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Equitas Small Finance Bank IPO, LIC Q2 Stake Hike in Companies, and Top Buzzing Stocks Today(Pre-Open)

It was indeed a volatile trading day for share markets in India yesterday. After staging a gap-up opening, Indian share markets reversed gains.

Views on news

GSK PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 2.2% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, GSK PHARMA has posted a net profit of Rs 1 bn (down 2.2% YoY). Sales on the other hand came in at Rs 6 bn (down 17.7% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, GSK PHARMA has posted a net profit of Rs 5 bn (up 398.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

More Views on News

Most Popular

My Latest Stock Recommendation (Fast Profits Daily)

Oct 9, 2020

How I picked an exciting stock using trends from both the commodity and equity markets.

The 'Seedhi Baat, No Bakwaas' View on ITC (Profit Hunter)

Oct 12, 2020

Is ITC an investment or a speculation at current levels?

One of the Best Investment Opportunities in the Market Right Now (Fast Profits Daily)

Oct 16, 2020

The one sector that you should be looking at to make good profits.

The Inflection Point for Defence Stocks is Getting Closer (Profit Hunter)

Oct 9, 2020

Few Indian defence companies could use their engineering capabilities to eventually become global leaders.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Oct 21, 2020 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GSK PHARMA

GSK PHARMA - FULFORD INDIA COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS